Wall Street Analysts Predict 45.3% Upside in Catalyst Pharmaceutical

Wall Street analysts predict a 45.3% upside in Catalyst Pharmaceutical (CPRX) with a mean price target of $34. The consensus price target is based on seven short-term price targets with a standard deviation of $1.63. Analysts also expect the company to report better earnings than initially estimated. However, it's essential to note that the accuracy of price targets has been questioned, and investors should not rely solely on this tool when making investment decisions.